Amid Shortages, U.S. Allows Expanded Production of ADHD Drug Vyvanse

THURSDAY, Sept. 5, 2024 -- The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues.

Following a request from the U.S. Food...